Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes.

Alonso-Miguel, Daniel; Fiering, Steven; Arias-Pulido, Hugo

Alonso-Miguel, Daniel; Fiering, Steven; Arias-Pulido, Hugo.

Afiliação

Alonso-Miguel D; Department of Animal Medicine and Surgery, Veterinary Medicine School, Complutense University of Madrid, 28040 Madrid, Spain.
Fiering S; Department of Microbiology and Immunology, and Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Lebanon, NH 03756, USA.
Arias-Pulido H; Department of Microbiology and Immunology, and Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Health, Lebanon, NH 03756, USA.

Cells ; 11(18)2022 09 13.

Article em En | MEDLINE | ID: mdl-36139425

Assuntos

Neoplasias Inflamatórias Mamárias; Antraciclinas; Humanos; Inibidores de Checkpoint Imunológico/uso terapêutico; Imunoterapia; Neoplasias Inflamatórias Mamárias/patologia; Neoplasias Inflamatórias Mamárias/terapia; Receptor de Morte Celular Programada 1; Taxoides

Palavras-chave

cowpea mosaic virus nanoparticles; immune checkpoint inhibitors; immunomodulators; in situ vaccination; inflammatory breast cancer; neoadjuvant immunotherapy; pembrolizumab; toll-like receptors; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Inflamatórias Mamárias Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google